• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Neuregulin-1β induces mature ventricular cardiac differentiation from induced pluripotent stem cells contributing to cardiac tissue repair.神经调节蛋白-1β可诱导诱导多能干细胞向成熟的心室心肌分化,有助于心脏组织修复。
Stem Cells Dev. 2015 Feb 15;24(4):484-96. doi: 10.1089/scd.2014.0211. Epub 2014 Nov 25.
2
Generation of electrophysiologically functional cardiomyocytes from mouse induced pluripotent stem cells.从小鼠诱导多能干细胞生成电生理功能正常的心肌细胞。
Stem Cell Res. 2016 Mar;16(2):522-30. doi: 10.1016/j.scr.2016.02.032. Epub 2016 Feb 23.
3
Efficient Cardiac Differentiation of Human Amniotic Fluid-Derived Stem Cells into Induced Pluripotent Stem Cells and Their Potential Immune Privilege.高效将人羊膜干细胞分化为诱导多能干细胞及其潜在免疫豁免。
Int J Mol Sci. 2020 Mar 29;21(7):2359. doi: 10.3390/ijms21072359.
4
Susceptibility of murine induced pluripotent stem cell-derived cardiomyocytes to hypoxia and nutrient deprivation.小鼠诱导多能干细胞衍生的心肌细胞对缺氧和营养剥夺的易感性。
Stem Cell Res Ther. 2015 Apr 23;6(1):83. doi: 10.1186/s13287-015-0057-6.
5
Transplantation of human induced pluripotent stem cell-derived cardiomyocytes improves myocardial function and reverses ventricular remodeling in infarcted rat hearts.人诱导多能干细胞衍生的心肌细胞移植可改善梗死大鼠心脏的心肌功能并逆转心室重构。
Stem Cell Res Ther. 2020 Feb 21;11(1):73. doi: 10.1186/s13287-020-01602-0.
6
Cyclin D2 Overexpression Enhances the Efficacy of Human Induced Pluripotent Stem Cell-Derived Cardiomyocytes for Myocardial Repair in a Swine Model of Myocardial Infarction.Cyclin D2 过表达增强了人诱导多能干细胞衍生的心肌细胞在心肌梗死后猪模型中的心肌修复效果。
Circulation. 2021 Jul 20;144(3):210-228. doi: 10.1161/CIRCULATIONAHA.120.049497. Epub 2021 May 6.
7
Induced pluripotent stem (iPS) cells repair and regenerate infarcted myocardium.诱导多能干细胞(iPS)可修复和再生梗死的心肌。
Mol Pharm. 2011 Oct 3;8(5):1573-81. doi: 10.1021/mp2001704. Epub 2011 May 24.
8
Reporter-based isolation of induced pluripotent stem cell- and embryonic stem cell-derived cardiac progenitors reveals limited gene expression variance.基于报道者的诱导多能干细胞和胚胎干细胞衍生的心脏祖细胞的分离揭示了有限的基因表达差异。
Circ Res. 2010 Aug 6;107(3):340-7. doi: 10.1161/CIRCRESAHA.109.215434. Epub 2010 Jun 17.
9
Efficient differentiation of human induced pluripotent stem cells generates cardiac cells that provide protection following myocardial infarction in the rat.高效分化人类诱导多能干细胞生成的心肌细胞可在大鼠心肌梗死后提供保护。
Stem Cells Dev. 2012 Apr 10;21(6):977-86. doi: 10.1089/scd.2011.0075. Epub 2012 Feb 15.
10
Inhibition of stearoyl-coA desaturase selectively eliminates tumorigenic Nanog-positive cells: improving the safety of iPS cell transplantation to myocardium.抑制硬脂酰辅酶A去饱和酶可选择性清除致瘤性Nanog阳性细胞:提高诱导多能干细胞移植至心肌的安全性。
Cell Cycle. 2014;13(5):762-71. doi: 10.4161/cc.27677. Epub 2014 Jan 6.

引用本文的文献

1
Induced pluripotent stem cell therapies in heart failure treatment: a meta-analysis and systematic review.诱导多能干细胞疗法在心力衰竭治疗中的应用:一项荟萃分析与系统评价
Regen Med. 2024 Sep-Oct;19(9-10):497-509. doi: 10.1080/17460751.2024.2393558. Epub 2024 Sep 12.
2
Transplantation of induced pluripotent stem cells-derived cardiomyocytes combined with modified Taohong Siwu decoction improved heart repair after myocardial infarction.诱导多能干细胞衍生的心肌细胞移植联合改良桃红四物汤可改善心肌梗死后的心脏修复。
Heliyon. 2024 Feb 20;10(4):e26700. doi: 10.1016/j.heliyon.2024.e26700. eCollection 2024 Feb 29.
3
Induced Pluripotent Stem Cell-Derived Cardiomyocytes Therapy for Ischemic Heart Disease in Animal Model: A Meta-Analysis.诱导多能干细胞衍生的心肌细胞治疗动物模型缺血性心脏病的Meta 分析。
Int J Mol Sci. 2024 Jan 12;25(2):987. doi: 10.3390/ijms25020987.
4
Overexpression of KCNJ2 enhances maturation of human-induced pluripotent stem cell-derived cardiomyocytes.KCNJ2 的过表达增强了人诱导多能干细胞衍生的心肌细胞的成熟。
Stem Cell Res Ther. 2023 Apr 15;14(1):92. doi: 10.1186/s13287-023-03312-9.
5
Prophylactic Evidence of MSCs-Derived Exosomes in Doxorubicin/Trastuzumab-Induced Cardiotoxicity: Beyond Mechanistic Target of NRG-1/Erb Signaling Pathway.间充质干细胞衍生外泌体在多柔比星/曲妥珠单抗诱导心脏毒性中的防护作用:超越 NRG-1/Erb 信号通路的机制靶点。
Int J Mol Sci. 2022 May 25;23(11):5967. doi: 10.3390/ijms23115967.
6
Modeling Hypoxic Stress In Vitro Using Human Embryonic Stem Cells Derived Cardiomyocytes Matured by FGF4 and Ascorbic Acid Treatment.使用 FGF4 和抗坏血酸处理的人胚胎干细胞衍生的心肌细胞体外模拟缺氧应激。
Cells. 2021 Oct 14;10(10):2741. doi: 10.3390/cells10102741.
7
Engineering aligned human cardiac muscle using developmentally inspired fibronectin micropatterns.利用发育启发的纤维连接蛋白微图案工程化排列的人心肌。
Sci Rep. 2021 Jun 1;11(1):11502. doi: 10.1038/s41598-021-87550-y.
8
Maturation strategies and limitations of induced pluripotent stem cell-derived cardiomyocytes.诱导多能干细胞衍生心肌细胞的成熟策略和限制。
Biosci Rep. 2021 Jun 25;41(6). doi: 10.1042/BSR20200833.
9
Neuregulin in Health and Disease.健康与疾病中的神经调节蛋白
Int J Brain Disord Treat. 2018;4(1). doi: 10.23937/2469-5866/1410024. Epub 2018 Nov 10.
10
Coculture of Endothelial Cells with Human Pluripotent Stem Cell-Derived Cardiac Progenitors Reveals a Differentiation Stage-Specific Enhancement of Cardiomyocyte Maturation.人多能干细胞源性心脏祖细胞与内皮细胞共培养揭示了心肌细胞成熟的分化阶段特异性增强。
Biotechnol J. 2019 Aug;14(8):e1800725. doi: 10.1002/biot.201800725. Epub 2019 May 14.

本文引用的文献

1
Cell persistence and electrical integration of transplanted fetal cardiomyocytes from different developmental stages.
Int J Cardiol. 2014 Feb 15;171(3):e122-4. doi: 10.1016/j.ijcard.2013.12.115. Epub 2014 Jan 4.
2
Neuregulin-1β induces embryonic stem cell cardiomyogenesis via ErbB3/ErbB2 receptors.神经调节蛋白-1β 通过 ErbB3/ErbB2 受体诱导胚胎干细胞心肌生成。
Biochem J. 2014 Mar 1;458(2):335-41. doi: 10.1042/BJ20130818.
3
Controlled delivery of fibroblast growth factor-1 and neuregulin-1 from biodegradable microparticles promotes cardiac repair in a rat myocardial infarction model through activation of endogenous regeneration.可控制递送达纤维化生长因子-1 和神经调节蛋白-1 的生物可降解微球通过激活内源性再生促进大鼠心肌梗死模型中的心脏修复。
J Control Release. 2014 Jan 10;173:132-9. doi: 10.1016/j.jconrel.2013.10.034. Epub 2013 Nov 5.
4
Electrophysiological integration and action potential properties of transplanted cardiomyocytes derived from induced pluripotent stem cells.诱导多能干细胞衍生的心肌细胞的电生理整合和动作电位特性。
Cardiovasc Res. 2013 Dec 1;100(3):432-40. doi: 10.1093/cvr/cvt213. Epub 2013 Sep 16.
5
Induced pluripotent stem cells as a new strategy for cardiac regeneration and disease modeling.诱导多能干细胞作为心脏再生和疾病建模的新策略。
J Mol Cell Cardiol. 2013 Sep;62:43-50. doi: 10.1016/j.yjmcc.2013.04.022. Epub 2013 Apr 30.
6
Induced pluripotent stem cell intervention rescues ventricular wall motion disparity, achieving biological cardiac resynchronization post-infarction.诱导多能干细胞干预挽救心室壁运动差异,实现梗死后的生物学心脏再同步。
J Physiol. 2013 Sep 1;591(17):4335-49. doi: 10.1113/jphysiol.2013.252288. Epub 2013 Apr 8.
7
Gene Ontology annotations and resources.基因本体论注释和资源。
Nucleic Acids Res. 2013 Jan;41(Database issue):D530-5. doi: 10.1093/nar/gks1050. Epub 2012 Nov 17.
8
Neuregulin in cardiovascular development and disease.神经调节蛋白在心血管发育和疾病中的作用。
Circ Res. 2012 Oct 26;111(10):1376-85. doi: 10.1161/CIRCRESAHA.112.267286.
9
Feasibility, safety, and therapeutic efficacy of human induced pluripotent stem cell-derived cardiomyocyte sheets in a porcine ischemic cardiomyopathy model.人诱导多能干细胞源性心肌细胞片在猪缺血性心肌病模型中的可行性、安全性和治疗效果。
Circulation. 2012 Sep 11;126(11 Suppl 1):S29-37. doi: 10.1161/CIRCULATIONAHA.111.084343.
10
Human ES-cell-derived cardiomyocytes electrically couple and suppress arrhythmias in injured hearts.人胚胎干细胞来源的心肌细胞在损伤心脏中电耦合并抑制心律失常。
Nature. 2012 Sep 13;489(7415):322-5. doi: 10.1038/nature11317.

神经调节蛋白-1β可诱导诱导多能干细胞向成熟的心室心肌分化,有助于心脏组织修复。

Neuregulin-1β induces mature ventricular cardiac differentiation from induced pluripotent stem cells contributing to cardiac tissue repair.

作者信息

Iglesias-García Olalla, Baumgartner Sven, Macrí-Pellizzeri Laura, Rodriguez-Madoz Juan Roberto, Abizanda Gloria, Guruceaga Elizabeth, Albiasu Edurne, Corbacho David, Benavides-Vallve Carolina, Soriano-Navarro Mario, González-Granero Susana, Gavira Juan José, Krausgrill Benjamin, Rodriguez-Mañero Moises, García-Verdugo Jose Manuel, Ortiz-de-Solorzano Carlos, Halbach Marcel, Hescheler Juergen, Pelacho Beatriz, Prósper Felipe

机构信息

1 Area of Cell Therapy, Center for Applied Medical Research, University of Navarra , Pamplona, Spain .

出版信息

Stem Cells Dev. 2015 Feb 15;24(4):484-96. doi: 10.1089/scd.2014.0211. Epub 2014 Nov 25.

DOI:10.1089/scd.2014.0211
PMID:25329043
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC4313422/
Abstract

Stem cell-derived cardiomyocytes (CMs) are often electrophysiologically immature and heterogeneous, which represents a major barrier to their in vitro and in vivo application. Therefore, the purpose of this study was to examine whether Neuregulin-1β (NRG-1β) treatment could enhance in vitro generation of mature "working-type" CMs from induced pluripotent stem (iPS) cells and assess the regenerative effects of these CMs on cardiac tissue after acute myocardial infarction (AMI). With that purpose, adult mouse fibroblast-derived iPS from α-MHC-GFP mice were derived and differentiated into CMs through NRG-1β and/or dimethyl sulfoxide (DMSO) treatment. Cardiac specification and maturation of the iPS was analyzed by gene expression array, quantitative real-time polymerase chain reaction, immunofluorescence, electron microscopy, and patch-clamp techniques. In vivo, the iPS-derived CMs or culture medium control were injected into the peri-infarct region of hearts after coronary artery ligation, and functional and histology changes were assessed from 1 to 8 weeks post-transplantation. On differentiation, the iPS displayed early and robust in vitro cardiogenesis, expressing cardiac-specific genes and proteins. More importantly, electrophysiological studies demonstrated that a more mature ventricular-like cardiac phenotype was achieved when cells were treated with NRG-1β and DMSO compared with DMSO alone. Furthermore, in vivo studies demonstrated that iPS-derived CMs were able to engraft and electromechanically couple to heart tissue, ultimately preserving cardiac function and inducing adequate heart tissue remodeling. In conclusion, we have demonstrated that combined treatment with NRG-1β and DMSO leads to efficient differentiation of iPS into ventricular-like cardiac cells with a higher degree of maturation, which are capable of preserving cardiac function and tissue viability when transplanted into a mouse model of AMI.

摘要

干细胞衍生的心肌细胞(CMs)在电生理方面通常不成熟且具有异质性,这是其在体外和体内应用的主要障碍。因此,本研究的目的是检验神经调节蛋白-1β(NRG-1β)处理是否能增强诱导多能干细胞(iPS)体外生成成熟的“工作型”CMs,并评估这些CMs对急性心肌梗死(AMI)后心脏组织的再生作用。为此,从α-MHC-GFP小鼠的成年成纤维细胞中获取iPS,并通过NRG-1β和/或二甲基亚砜(DMSO)处理将其分化为CMs。通过基因表达阵列、定量实时聚合酶链反应、免疫荧光、电子显微镜和膜片钳技术分析iPS的心脏定向分化和成熟情况。在体内,将iPS衍生的CMs或培养基对照注射到冠状动脉结扎后心脏的梗死周边区域,并在移植后1至8周评估功能和组织学变化。在分化过程中,iPS在体外显示出早期且强劲的心脏发生,表达心脏特异性基因和蛋白质。更重要的是,电生理研究表明,与单独使用DMSO相比,用NRG-1β和DMSO处理细胞时可实现更成熟的心室样心脏表型。此外,体内研究表明,iPS衍生的CMs能够植入心脏组织并与之进行机电耦合,最终维持心脏功能并诱导适当的心脏组织重塑。总之,我们已经证明,NRG-1β和DMSO联合处理可导致iPS高效分化为具有更高成熟度的心室样心脏细胞,将其移植到AMI小鼠模型中时能够维持心脏功能和组织活力。